Tim Casey

Feature

Atorvastatin Is More Cost-Effective than Rosuvastatin or Simvastatin/Ezetimibe

02/15/2011

Anaheim—An analysis of 3-year patient drug costs for branded statin therapies found that patients taking atorvastatin were less costly for managed care health plans to cover than patients taking rosuvastatin or a combination of simvastatin...

Anaheim—An analysis of 3-year...

02/15/2011

First Report Managed Care

Feature

Ruxolitinib in Patients with Myelofibrosis

07/19/2011

Tim Casey ;

Chicago—A phase 3 trial found that ruxolitinib showed a clinical benefit in reducing spleen size and significantly improved disease-related symptoms, functioning, and quality of life in patients with myelofibrosis compared with the best...

Chicago—A phase 3 trial found...

07/19/2011

First Report Managed Care

Conference Insider

Transitioning Toward a Consumer-Centric Approach in Healthcare

06/26/2013

Tim Casey ;

Orlando—As a partner in Oliver Wyman’s Health & Life Sciences group, Michael Lovdal, PhD, is accustomed to people asking or complaining about the problems associated with healthcare spending. Recently, an acquaintance told him he thought the...

Orlando—As a partner in Oliver...

06/26/2013

First Report Managed Care

Conference Insider

Implementation of Accountable Care Organizations

06/19/2012

Tim Casey ;

Orlando—Soon after the Department of Health and Human Services (HHS) announced the proposed regulations for accountable care organizations (ACOs) in March 2011, many constituencies in the healthcare industry derided the rules as too...

Orlando—Soon after the...

06/19/2012

First Report Managed Care

News Connection

Healthcare Reform Big Issue in Elections

10/21/2010

Tim Casey ;

Leading up to the November elections, the political parties spent countless hours and millions of dollars debating the merits of the Patient Protection and Affordable Care Act (HR 3590).

Leading up to the November...

10/21/2010

First Report Managed Care

Specialty Pharmacies Helping to Evaluate Data and Use Technology to Reduce Costs and Improve Quality

06/19/2014

Tim Casey ;

Tampa—Within the next 5 years, specialty pharmaceuticals are expected to account for more than half of the overall drug spending in the United States. By 2016, 8 of the top 10 branded drugs will be specialty medications, while 53 specialty...

Tampa—Within the next 5 years,...

06/19/2014

First Report Managed Care

Stenting Added to Medical Therapy for Atherosclerotic Renal Artery Stenosis

01/21/2014

Tim Casey ;

Dallas—Stenting added to medical therapy did not reduce the rate of major cardiovascular and renal events compared with medical therapy alone in patients with atherosclerotic renal artery stenosis and hypertension or chronic kidney disease,...

Dallas—Stenting added to medical...

01/21/2014

First Report Managed Care

Survey on Oncology Drug Shortages

08/15/2013

Tim Casey ;

Chicago—According to a survey, most oncologists and hematologists have faced drug shortages in recent years and have had to deny, delay, or modify treatment regimens for cancer patients. Although the scarcity of these drugs has received...

Chicago—According to a survey,...

08/15/2013

First Report Managed Care

PCI versus Pharmaco-Invasive Regimen in STEMI Patients

04/22/2013

Tim Casey ;

San Francisco—Patients with ST-elevation myocardial infarction (STEMI) treated at community hospitals or in ambulances had similar results whether they underwent percutaneous coronary intervention (PCI) or received a pharmaco-invasive...

San Francisco—Patients with...

04/22/2013

First Report Managed Care

Uncertainty about ACA Fades

01/22/2013

Tim Casey ;

At the beginning of 2012, the future of the Patient Protection and Affordable Care Act (ACA) seemed uncertain. More than a dozen states had sued to have the healthcare reform law overturned and Republican presidential candidates vowed to...

At the beginning of 2012, the...

01/22/2013

First Report Managed Care